[The characteristics of the action of a chemical immunomodulator in a latent viral infection].
Kalenderov
A K
AK
Semenova
I B
IB
D000119:Acetylmuramyl-Alanyl-Isoglutamine / Q000031:analogs & derivatives* / Q000627:therapeutic use; D000276:Adjuvants, Immunologic / Q000627:therapeutic use*; D000818:Animals; D004353:Drug Evaluation, Preclinical; D002141:Encephalitis Virus, California; D004670:Encephalitis, California / Q000188:drug therapy* / Q000276:immunology; D007108:Immune Tolerance / Q000187:drug effects / Q000276:immunology; D051379:Mice; D008808:Mice, Inbred CBA
D000276:Adjuvants, Immunologic; C089161:glikopin; D000119:Acetylmuramyl-Alanyl-Isoglutamine
Osobennosti deĭstviia khimicheskogo immunomoduliatora pri latentnoĭ virusnoĭ infektsii.